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Abstract
Background: Pre-eclampsia is associated with an increased risk of development of cardiovascular
disease later in life. It is not known how general practitioners in the Netherlands care for these
women after delivery with respect to cardiovascular risk factor management.
Methods: Review of medical records of 1196 women in four primary health care centres, who
were registered from January 2000 until July 2007 with an International Classification of Primary
Care (ICPC) code indicating pregnancy. Records were searched for indicators of pre-eclampsia. Of
those who experienced pre-eclampsia and of a random sample of 150 women who did not, the
following information on cardiovascular risk factor management after pregnancy was extracted
from the records: frequency and timing of blood pressure, cholesterol and glucose measurements
- and vascular diagnoses. Additionally the sensitivity and specificity of ICPC coding for pre-
eclampsia were determined.
Results: 35 women experienced pre-eclampsia. Blood pressure was more often checked after
pregnancy in these women than in controls (57.1% vs. 12.0%, p < 0.001). In 50% of the cases blood
pressure was measured within 3 months after delivery with no further follow-up visit. A check for
glucose and cholesterol levels was rare, and equally frequent in PE and control women. 20% of the
previously normotensive women in the PE group had hypertension at one or more occasions after
three months post partum versus none in the control group. The ICPC coding for pre-eclampsia
showed a sensitivity of 51.4% and a specificity of 100.0%.
Conclusion: Despite the evidence of increased risk of future cardiovascular disease in women
with a history of pre-eclampsia, follow-up of these women is insufficient and undeveloped in
primary care in the Netherlands.
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Background
Women with a history of pre-eclampsia (PE) during preg-
nancy have an increased risk of chronic hypertension later
in life as compared to nulliparous women and women
with an uncomplicated pregnancy. In addition, a number
of large cohort studies have indicated an increased risk of
several other cardiovascular conditions such as over-
weight and diabetes in later years among women who
experienced PE or eclampsia during their pregnancy [1-5].
We recently showed that women with a high blood pres-
sure in pregnancy had a 57% increased risk of developing
coronary calcifications later in life [6]. Furthermore, in a
recent meta-analysis it was shown that a history of PE
increases the risk of future ischemic heart disease, stroke
and other vascular diseases [7]. The primary care physi-
cian may play an important role in the follow-up of these
women after pregnancy, in terms of early identification of
high risk subjects and early initiation of treatment of
hypertension and other risk factors for CVD. As yet, spe-
cific guidelines or protocols for general practitioners
(GPs) on cardiovascular risk factor management of
women with a pregnancy complicated by PE do not exist.
In fact, in the Netherlands routine blood pressure meas-
urements are made, and only when the GP considers a
patient at high risk of having elevated blood pressure. Pre-
vious pre-eclampsia is generally not considered as identi-
fier of such a high risk group. In addition, it is not known
how GPs in the Netherlands care for women who experi-
enced a hypertensive disorder during their pregnancy after
the child is born.
We set out to investigate the extent of cardiovascular risk
factor management in general practice in women with a
history of PE. Additionally we compared the International
Classification of Primary Care (ICPC) coding for these
disorders in the GPs registries with clinical information




The study population comprised all inhabitants of
Leidsche Rijn, a geographically well defined new suburb
near Utrecht, The Netherlands. Studies with routine
healthcare data from this population are carried out in the
"Utrecht Health Project" which is a research infrastructure
closely linked to primary health care in Leidsche Rijn [8].
The primary health care is delivered by 4 general practices,
comprising approximately 18 GPs. The GPs use electronic
medical dossiers (EMD) and as part of their usual practice
all conditions of the patients are classified according to
the International Classification of Primary Care. The GPs
and assistants are trained and supported in computerized
recording and coding [9]. The study has been approved by
the Medical Ethics Committee of the University Medical
Centre Utrecht. All participants gave written informed
consent. The electronic medical dossiers over the period
January 1 2000 - July 12 2007 were used to define our
study population.
We identified ICPC codes potentially dealing with preg-
nancy (additional file 1). The corresponding medical
charts were manually reviewed to determine the exact
number of pregnancies and to identify potentially
wrongly coded records. We confirmed the presence of an
ongoing pregnancy when, in addition to the ICPC code,
information was available in the records indicating preg-
nancy (e.g. confirmed pregnancy, positive pregnancy test
without a recorded miscarriage or abortion within the
study period, birth, intra-uterine death or birth of a dead
child after 20 weeks of gestation, breastfeeding or mastitis
in combination with breastfeeding, or consultations
regarding episiotomy). Women with charts indicating a
pregnancy before January 1 2000, miscarriage or abortion
before 20 weeks of gestation, recording of positive preg-
nancy test without the possibility of birth (e.g. because of
restricted study time period or future pregnancy) and mas-
titis without mentioning of breastfeeding, were consid-
ered not to be pregnant.
All records identified as pregnancy were subsequently
screened on history of PE. We considered a pregnancy as
pre-eclamptic when a specified diagnosis of PE, or one of
the more severe forms of PE, eclampsia or HELLP syn-
drome, were recorded in the EMD by the GP (or gynaecol-
ogist through correspondence with the GP). Eclampsia
was defined as the occurrence of seizures in a pre-eclamp-
tic patient. HELLP syndrome was defined to be a true case
when this disorder was explicitly reported by the GP. Also
women who in our opinion were strongly suspected to be
PE cases according to the charts (e.g. by described combi-
nations of hypertension and 'substantial' proteinuria)
were selected. Of women who had more than one preg-
nancy during our follow-up observation period, we
always used the information regarding the first pregnancy.
To compare cardiovascular risk factor management in the
PE women with women whose pregnancy was uncompli-
cated, we randomly selected 150 women as control group.
Collection of study population characteristics
Age of the women was determined at the time of delivery.
Medical records were searched for signs of hypertension in
a previous pregnancy, pre-existing vascular disease and
chronic hypertension, because awareness of these condi-
tions might influence cardiovascular risk management by
the GP. Indications of hypertension already existing
before pregnancy were the use of antihypertensive medi-
cation, multiple hypertensive blood pressure measure-
ments or diagnosis recorded by the GP.BMC Family Practice 2009, 10:77 http://www.biomedcentral.com/1471-2296/10/77
Page 3 of 6
(page number not for citation purposes)
Follow-up time and the number and content of visits to
the GP after pregnancy were determined, recording the
frequency and timing of blood pressure, cholesterol and
glucose measurements. Measurements obviously not
related to the pregnancy or the pre-eclampsia, for example
in case of fever, were excluded. Furthermore we screened
on future (vascular) diagnoses by searching for specific
ICPC codes (additional file 2) and vascular conditions or
risk factors reported by the GP.
Statistical analyses
Data are presented descriptively, providing number of
women, mean values and standard deviations, or percent-
ages. The differences between the PE cases and controls
were investigated using t-test for continuous data, and χ2-
test or Fisher exact test for categorical data as appropriate.
To verify the value of the ICPC coding for PE (W81,
W81.1, W81.2, W81.3) we compared the PE codes with
the information found in the records of all pregnant
women. Subsequently, a 2 × 2 table was constructed and
sensitivity, specificity, positive and negative predictive
value were calculated. Data were analysed using SPSS for
Windows (version 14.0, SPSS Inc., Chicago, Illinois,
USA).
Results
ICPC and chart findings
Our search yielded 1196 women with 2232 pregnancies.
Eighteen pregnancies (in eighteen women) were coded as
having been complicated with a PE: W81 (n = 10), W81.1
(n = 1), W81.2 (n = 5) and W81.3 (n = 2). After examina-
tion of the charts, all patients were considered truly to
have had pre-eclampsia. The review of the charts of the
remaining 2214 pregnancies yielded another 17 patients
diagnosed with PE, without a correct ICPC code. In total
35 patients experienced a PE (PE group), of which 2 devel-
oped eclampsia, and 5 developed the HELLP syndrome.
The ICPC coding for PE (combining W81, W81.1, W81.2,
and W81.3) was calculated, showing a sensitivity of
51.4% and a specificity of 100.0%. The positive and neg-
ative predictive values were 100.0% and 99.2%, respec-
tively.
Patient characteristics
Characteristics of women with and without PE are given
in Table 1.
Follow-up and risk factor management
Mean follow-up time was 2.9 years in the PE group and
2.5 years in the control group.
Blood pressure measurements were more often registered
in women with a pregnancy complicated with PE than in
women with an uncomplicated pregnancy (57.1% vs.
12.0% respectively, p < 0.001) (Table 2). The timing of the
blood pressure measurements in the PE group varied. BP
measurements were only found in the first 4 weeks post-
partum in 35%, and up to 6 months in 25% of the women
followed up.
The women in the PE group with an indication of chronic
hypertension (n = 5) all had blood pressure measure-
ments after delivery. In four of them these measurements
were found only within three weeks, and within two,
three and four months after delivery respectively.
In only 8 out of 30 women without signs of chronic
hypertension the registration of blood pressure measure-
ments continued after three months. Six of these women
still had one or more hypertensive measurements after
this period.
Of the 18 women who were coded by the GP as having
had pre-eclampsia (W81, W81.1, W81.2, or W81.3),
61.1% had blood pressure measurements after delivery. In
54.5% of these women measurements took place within 3
months after delivery. For the women without the correct
ICPC code, these numbers were 52.9% (Chi-square, p =
0.63) and 44.4% respectively (Fisher exact, p = 1.00).
In the PE group, the reason for the measurement recorded
in the medical charts by the GP was in most cases because






Nullipara (%) 75.8 58.7 0.07‡
Mean age (y) ± SD 31.9 ± 3.6 32.4 ± 3.8 0.49†
Hypertension in previous pregnancy (%) 5.7 3.3 0.62§
Chronic hypertension (%) 14.3 4.0 0.02‡
Pre-existing vascular disease (%) 0.0 0.7 1.00§
NA, not applicable
†t test for independent samples
‡ Chi-square test
§Fisher exact testBMC Family Practice 2009, 10:77 http://www.biomedcentral.com/1471-2296/10/77
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of the pre-eclampsia (70%), in the other women measure-
ments were performed because of non-resolving hyper-
tension (30%). In the control group various indications
were recorded in the charts, including routine controls
after birth, hypertension, complaints suspect for vascular
disease such as chest pain, or screening for familial vascu-
lar diseases.
There were few glucose controls and cholesterol checks
found in the medical records, and comparable between
groups. Reasons for checking these risk factors recorded
by the GP included screening for diabetes, familial high
cholesterol or familiar vascular disease.
In the charts of 9 women of the PE group, one or more risk
factors for vascular disease (e.g. obesity, diabetes, family
history of cardiovascular disease and hypertension) were
already present before the index pregnancy. After delivery,
only two of these women were seen for these risk factors.
Discussion
In this study we compared cardiovascular follow-up per-
formed by GPs after pre-eclampsia and normotensive
pregnancy. Fifteen out of the 35 women (42.9%) who
experienced pre-eclampsia did not have blood pressure
checks after pregnancy in their medical records. Glucose
and cholesterol check ups were rare and similar among
women with and without a PE.
Strengths and limitations of the study
The strength of the current study lies in the fact that the
data were obtained in a large community based cohort
taken from primary practices, and in the suitability of the
design to assess cardiovascular risk management after pre-
eclampsia in routine and representative practice. How-
ever, the study had a small number of PE cases, which lim-
its wide extrapolation of our findings due to the limited
precision. Our study relied on the quality of the registra-
tion by the GPs. Although participating GPs were trained
in working with electronic medical records, it might be
possible that the GP did not report negative findings as
often as positive ones, e.g. a normal blood pressure or
negative family history, which would lead to a systematic
underestimation of cardiovascular risk management by
the GP. Some blood pressure check-ups might also not
have been found in the medical records because they were






Mean follow-up time (y) ± SD 2.9 (1.9) 2.5 (1.8) 0.29†
Blood pressure control 20 (57.1) 18 (12.0) < 0.001§
Frequency
1 time 5 (25.0) 10 (55.6)
2 times 3 (15.0) 4 (22.2)
≥ 3 times 13 (65.0) 4 (22.2)
Indication
PE/partus related 14 (70.0) 2 (11.8)
Hypertension 6 (30.0) 5 (29.4)
Complaints of vascular disease 0 (0.0) 5 (29.4)
Screening/control 0 (0.0) 5 (29.4)
Timing
0-4 wks 7 (35.0) 3 (16.7)
4-12 wks 4 (15.0) 0 (0.0)
12-26 wks 5 (25.0) 0 (0.0)
26-52 wks 0 (0.0) 0 (0.0)
≥ 52 wks 5 (25.0) 15 (83.3)
Glucose control 1 (3.0) 5 (3.3) 1.00‡
Cholesterol control 3 (9.1) 7 (4.7) 0.39‡
Cardiovascular diagnoses
Hypertension*> 3 months postpartum 6/30**(20.0) 0 (0.0) < 0.001‡
Hypercholesterolemia 0 (0.0) 1 (0.7) 1.00‡
Gestational hypertensive disorder 2 (6.1) 1 (0.7) 0.08‡
Cardio-/cerebrovascular disorder 1 (3.0) 3 (2.0) 1.00‡
Data reported as n (%) unless otherwise noted.
*≥1 measurement(s) of ≥140/90 mmHg
**Previously non-hypertensive women
† Mann Whitney U test
§ Chi-square test
‡ Fisher exact testBMC Family Practice 2009, 10:77 http://www.biomedcentral.com/1471-2296/10/77
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measured by others then the GPs or by the patients them-
selves. In case of a pre-eclamptic pregnancy, women are
normally invited for a blood pressure check-up six weeks
after delivery. This check-up might be performed by the
gynaecologist, the midwife or the GP. However, after this
final control, women will not visit the gynaecologist nor
midwife and will depend on their GP for blood pressure
control.
In this study not all women with PE were coded as such by
the GP. It could be hypothesized that GPs act differently
with respect to follow-up when they explicitly code a preg-
nancy as pre-eclamptic. The number of women with
blood pressure measurements after delivery and the tim-
ing of these measurements however, did not differ signif-
icantly between cases explicitly coded by the GP as PE,
and cases without the correct ICPC code.
Comparison with existing literature
Only a few studies, to our knowledge, have looked into
maternity care after PE. In the study of Samwiil and co-
workers [10], women with pregnancies complicated by
pre-eclampsia were visited between six weeks and three
months postpartum and were asked to recall if they had
their blood pressure and urine tested at their six-week
postnatal check. Of 257 audit participants across 21
maternity units in the United Kingdom, 91% recalled hav-
ing had their blood pressure taken and 15% recalled hav-
ing had their urine tested in general practices. In this
study, 11% showed signs of unresolved pre-eclampsia.
Macdonald and co-workers [11] evaluated the communi-
cation between maternity care providers and knowledge
about the association between PE and future vascular dis-
ease via a survey. Only 54% of the participants were famil-
iar with the long-term risks of hypertension after pre-
eclampsia. Most care providers (83%) stated that they
inform the patient's primary care physician about the
hypertensive disorder in pregnancy, but few either
informed the GP of the subsequent risk of hypertension
(36%), or provided recommendations for follow-up
(41%). Only 58% of the GPs reported that they are usu-
ally informed by the maternity care providers about their
patients who developed a hypertensive disorder, and very
few (12%) reported being informed regularly that such
women are at risk for subsequently developing hyperten-
sion. The authors concluded that there are weaknesses in
knowledge base and communication amongst maternity
care providers that suggest that the identification and fol-
low-up of women with hypertensive disorders of preg-
nancy is not occurring. Lack of knowledge could be a
possible explanation for our finding that over 40% of the
women who experienced pre-eclampsia never had a blood
pressure check-up after pregnancy and that no more glu-
cose and cholesterol check ups were performed compared
with women who did not suffer from pre-eclampsia. It is
possible that this was done by gynaecologists, however
even if this is the case, it was not recorded in the patients
medical charts. This might imply that GPs do not yet
intensify their vascular risk policy towards women who
experienced PE. Of note, in the Netherlands blood pres-
sure measurements are not routinely taken when a
woman visits her GP for other reasons.
Validation ICPC coding
While ICPC codes are often used to estimate incidence or
prevalence of certain health conditions or to select poten-
tial study objects, we are not aware of literature describing
the validity of pre-eclampsia-related diagnoses collected
in GPs registries. Our findings indicate that in the Utrecht
Health Project ICPC codes for PE are correctly reported by
the GP. Thus the use of ICPC codes can be recommended
for etiologic studies into determinants of PE using a case
control design. If the intention is to determine the inci-
dence of PE, the sensitivity of ICPC codes is not accurate
enough (missing over 50% of the cases).
There is no specific ICPC code for gestational hyperten-
sion only. Although the risk of future cardiovascular dis-
ease is lower for women who experienced gestational
hypertension compared to women who experienced pre-
eclampsia, the risk is still higher than for women who did
not develop hypertension during pregnancy at all. Fur-
thermore, the incidence of gestational hypertension is
much higher compared to pre-eclampsia (about 10-15%).
Probably, part of these women actually has chronic hyper-
tension, mistaken for gestational hypertension due to the
physiological fall in blood pressure that occurs early in
pregnancy and the rise to or above the prepregnancy level
in the second half of pregnancy. Because many young
women have their first blood pressure measurements dur-
ing pregnancy, ICPC coding for gestational hypertension
might form a screening opportunity for chronic hyperten-
sion, which is under diagnosed in the Netherlands.
Implications for future research or clinical practice
Our study showed a convincing number of patients in the
PE group with probably ongoing or arising hypertensive
disease after delivery. In at least six women hypertension
existed longer then 3 months postpartum. In the other
women follow-up did not last three months or blood
pressure was not measured at all after pregnancy; the
number of women with probably persistent (or chronic)
hypertension is therefore likely to be higher.
Pregnancy may be considered as an important screening
opportunity for cardiovascular and metabolic risk factors,
identifying women who are at risk of cardiovascular dis-
ease later in life. Women might benefit from long term
follow-up in terms of earlier diagnosis, intervention,
counselling, life style changes and risk factor modifica-BMC Family Practice 2009, 10:77 http://www.biomedcentral.com/1471-2296/10/77
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tion, with the ultimate aim to prevent future mortality
and morbidity. Trial data on this issue is however lacking.
Although it has been shown that women with a history of
PE have an increased risk of not only chronic hyperten-
sion, but also of other cardiovascular conditions such as
overweight and diabetes, the value of glucose and lipid
measurement for identification of high risk groups is still
unknown in this population. Furthermore, the 2007
update of the evidence-based guidelines for cardiovascu-
lar disease prevention in women by the American Heart
Association states that future research should first evaluate
the potential for medical contact during pregnancy to
identify women at high risk. More research is needed on
this aspect, and the necessity of development of screening
and counselling guidelines deserves more attention and
effort.
Conclusion
In spite of the evidence of their increased risk of future car-
diovascular disease, follow-up in women with a history of
pre-eclampsia, is insufficient and undeveloped in primary
care in the Netherlands, possibly due to a lack of knowl-
edge and poor communication amongst obstetric and pri-
mary care providers.
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